Search

everythinglearnresearchcommunity

for

Search:↓

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Acne is an important sign of androgen excess disorders in women.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Using SVF enriched with PRP in surgery for certain fistulas is effective and safe.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Hair loss may indicate higher heart risk and metabolic issues.